Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
jiahua lyu, doctor
CONTACT
Lead
Sichuan Cancer Hospital and Research Institute
This study evaluated the effectiveness and safety of Camrelizumab combination with SBRT and concurrent chemotherapy treated stage IV oligometastatic non-small cell lung cancer. The primary endpoint is ORR. Secondary points contains:PFS、OS、DCR、Qol.
Age
18–75
Sex
ALL
Healthy volunteers
Accepted
